582 filings
ARS
2023 FY
KURA
Kura Oncology Inc
18 Apr 24
Annual report to shareholders
4:05pm
DEFA14A
KURA
Kura Oncology Inc
12 Apr 24
Additional proxy soliciting materials
4:26pm
DEF 14A
KURA
Kura Oncology Inc
Definitive proxy
12 Apr 24
4:26pm
UPLOAD
KURA
Kura Oncology Inc
29 Feb 24
Letter from SEC
12:00am
S-8
KURA
Kura Oncology Inc
27 Feb 24
Registration of securities for employees
4:52pm
10-K
2023 FY
KURA
Kura Oncology Inc
Annual report
27 Feb 24
4:05pm
8-K
KURA
Kura Oncology Inc
27 Feb 24
Kura Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
4:03pm
424B3
KURA
Kura Oncology Inc
15 Feb 24
Prospectus supplement
4:01pm
EFFECT
KURA
Kura Oncology Inc
15 Feb 24
Notice of effectiveness
12:15am
SC 13G/A
EcoR1 Capital, LLC
14 Feb 24
Kura Oncology / EcoR1 Capital ownership change
5:58pm
SC 13G/A
Biotechnology Value Fund L P
14 Feb 24
Kura Oncology / BIOTECHNOLOGY VALUE FUND L P ownership change
9:39am
CORRESP
KURA
Kura Oncology Inc
14 Feb 24
Correspondence with SEC
12:00am
SC 13G/A
KURA
Kura Oncology Inc
13 Feb 24
Kura Oncology / SUVRETTA CAPITAL MANAGEMENT ownership change
5:23pm
SC 13G/A
Vanguard Group Inc
13 Feb 24
Kura Oncology / VANGUARD ownership change
5:08pm
CORRESP
KURA
Kura Oncology Inc
13 Feb 24
Correspondence with SEC
12:00am
SC 13G/A
Flynn James E
12 Feb 24
Kura Oncology / Flynn James E ownership change
5:33pm
S-3
KURA
Kura Oncology Inc
Shelf registration
9 Feb 24
5:21pm
D
KURA
Kura Oncology Inc
5 Feb 24
Exempt offering of security
12:00am
4
Thomas James Doyle
31 Jan 24
Kura Oncology / THOMAS JAMES DOYLE ownership change
5:30pm
4
KURA
Kura Oncology Inc
31 Jan 24
Kura Oncology / KATHLEEN FORD ownership change
5:30pm